about
The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-AnalysisWhich method of adherence measurement is most suitable for daily use to predict virological failure among immigrant and non-immigrant HIV-1 infected patients?Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysisLong-term MRA follow-up after coiling of intracranial aneurysms: impact on mood and anxiety.Quality of life after surgical decompression for a space-occupying middle cerebral artery infarct: A cohort study.Retention in HIV Care and Predictors of Attrition from Care among HIV-Infected Adults Receiving Combination Anti-Retroviral Therapy in Addis Ababa.HIV stigma and depressive symptoms are related to adherence and virological response to antiretroviral treatment among immigrant and indigenous HIV infected patients.Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIVElectronic medication monitoring-informed counseling to improve adherence to combination anti-retroviral therapy and virologic treatment outcomes: a meta-analysis.Health-related quality of life and survival among HIV-infected patients receiving highly active antiretroviral therapy: a study of patients in the AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort.Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.Patients' willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands.Health-related quality of life and posttraumatic stress disorder among survivors of an outbreak of Legionnaires disease.Sub-optimal adherence to combination anti-retroviral therapy and its associated factors according to self-report, clinician-recorded and pharmacy-refill assessment methods among HIV-infected adults in Addis Ababa.Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.Development of the patient Harvey Bradshaw index and a comparison with a clinician-based Harvey Bradshaw index assessment of Crohn's disease activity.Impact of genital warts on emotional and sexual well-being differs by gender.Impact of HIV care facility characteristics on the cascade of care in HIV-infected patients in the Netherlands.High level of virological suppression among HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa, Ethiopia.Health-Related Quality of Life and Sexual Functioning of HIV-Positive Men Who Have Sex With Men Who Are Treated for Anal Intraepithelial Neoplasia.Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting.Health-related quality of life of HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa.A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial.Semipermanent filler treatment of HIV-positive patients with facial lipoatrophy: long-term follow-up evaluating MR imaging and quality of life.Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART.Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response.Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.Therapeutic drug monitoring of HIV-protease inhibitors to assess noncompliance.Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations.Patients' preferences regarding the timing of highly active antiretroviral therapy initiation for chronic asymptomatic HIV-1 infection.Prevalence of lipoatrophy and mitochondrial DNA content of blood and subcutaneous fat in HIV-1-infected patients randomly allocated to zidovudine- or stavudine-based therapy.The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle.Effect of bosentan on exercise capacity and quality of life in adults with pulmonary arterial hypertension associated with congenital heart disease with and without Down's syndrome.Prediction of virological failure in HIV-infected individuals treated with cART in Suriname.Supportive care for women with recurrent miscarriage: a survey to quantify women's preferences.Treatment preferences and trade-offs for ovulation induction in clomiphene citrate-resistant patients with polycystic ovary syndrome.Statistical or clinical improvement? Determining the minimally important difference for the vascular quality of life questionnaire in patients with critical limb ischemia.
P50
Q26865049-BD76CFF2-B255-4BBA-9C74-A4074FCFB5F7Q29353869-54CBC566-D447-4F4A-B93C-147313E1B15FQ34088434-D281F572-1094-48EC-8FA4-BD98B76B45ABQ34103635-936B49D8-F49F-4B6F-BCBD-2A160D100105Q34801380-F252AE57-211A-4C9F-A668-162503DCBC9FQ35756757-A7EA7FD1-46CC-44D6-8827-E8D3DD8F6838Q35788262-EEF50084-1044-41E8-AE8B-FC7F2A620460Q36106528-0D6482AC-9394-4111-A34B-B11A2BF65DDAQ36153952-A54281EA-B416-4BBA-A92E-5789B9B012D5Q37022939-B5DEE577-8D93-417E-9220-7732A40F7E37Q38515374-DF772F9B-ED62-48D1-BFD2-F6ED37584D2DQ38964794-9D8F4557-E69D-4B5B-9491-3469F03617B7Q38985301-74D9F294-0B46-44A4-A70E-237591AD0B7DQ39098480-0C990213-5E7D-48B1-A32B-6BDEC39339D5Q39172610-FD8D199F-15AB-4AB5-A4B6-C1A7B8612589Q39324005-191A1A2C-505A-4A85-AA16-2FEE19175C61Q39333242-9B053DF0-07D1-4171-8771-80DBFDAB0951Q39427413-5B363F24-E00E-405F-BD9C-822BEF5DA31DQ39565796-05ED2FD4-F7D4-4A56-81E8-CF2342590346Q40184174-01909A82-D89D-40FB-A529-4E8F6316FE44Q40845404-9D68D138-55AE-4897-A384-41E54F256104Q40877581-140A9487-7BC2-4AD1-8875-BE02793F4F12Q40896330-1587CE0A-0EF9-4343-9132-9D3A8828E57CQ41202549-C6785629-F047-46AF-B39D-624FCD56A594Q42241206-66028BB3-D9E3-4757-9BFB-E09822E02026Q42249406-DF5886FE-0BD3-44B5-8CB7-41BF8439FB85Q43424863-CFDC07C0-E453-4B5A-9BD3-DB87B1C091EDQ43699708-F8D122B0-5D70-40CD-9AC1-4468772D599CQ43962523-96D7469E-CAD3-48AA-A8AD-31443BA79946Q44157271-5E7F19AA-7A62-4185-B146-8E20D03E5CE8Q44291459-84D49E35-9F3A-45FA-BB7C-686FB6BBDBA6Q44749137-B96B0C36-4BD9-47B8-B97C-CCBFF20B9F0FQ44983390-C8EA9DF7-36EE-4DFD-A83C-5E7B0DA782D2Q45908618-18E72992-0324-47AB-BEFC-95ED35238299Q45940594-678B049F-BB9F-45DB-ABDF-CDE745C7A5D8Q46030207-3BCFDB10-7875-4958-8118-597043B42A40Q46551509-83BAFB02-0ED1-4EDA-9050-6AB77B5FE4D0Q46592625-0BDB80C5-7EA9-4AB0-9F11-F87C95AE0916Q46638539-C9FDCB4A-3BFF-4552-8498-BC81F5F36C18Q46773091-964601D4-33FE-4F1F-9CE5-0BC7A32961BE
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Pythia T Nieuwkerk
@ast
Pythia T Nieuwkerk
@en
Pythia T Nieuwkerk
@es
Pythia T Nieuwkerk
@nl
Pythia T Nieuwkerk
@sl
type
label
Pythia T Nieuwkerk
@ast
Pythia T Nieuwkerk
@en
Pythia T Nieuwkerk
@es
Pythia T Nieuwkerk
@nl
Pythia T Nieuwkerk
@sl
altLabel
Pythia T Nieuwkerk
@en
prefLabel
Pythia T Nieuwkerk
@ast
Pythia T Nieuwkerk
@en
Pythia T Nieuwkerk
@es
Pythia T Nieuwkerk
@nl
Pythia T Nieuwkerk
@sl
P1006
P214
P1006
P1053
S-4084-2017
P106
P1960
jMW6HrIAAAAJ
P2038
Pythia_Nieuwkerk2
P21
P213
0000 0003 9420 1892
P214
P2798
P31
P3829
P496
0000-0002-2616-1414
P7859
viaf-288661528